Gubra A/S (CPH:GUBRA)

Denmark flag Denmark · Delayed Price · Currency is DKK
375.00
-20.80 (-5.26%)
Mar 6, 2026, 4:59 PM CET
Market Cap6.46B -40.8%
Revenue (ttm)2.64B +892.2%
Net Income1.69B
EPS102.70
Shares Out16.33M
PE Ratio3.85
Forward PE164.92
Dividendn/a
Ex-Dividend Daten/a
Volume59,016
Average Volume37,571
Open385.60
Previous Close395.80
Day's Range351.00 - 385.60
52-Week Range318.40 - 571.00
Beta0.16
RSI43.83
Earnings DateFeb 27, 2026

About Gubra

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinfor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 275
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol GUBRA
Full Company Profile

Financial Performance

Financial Statements